Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Allergy Therapeutics unveils new non-executive director

Jean-Yves Pavee retired from the board last night and has been replaced by Jeff Barton, who has been nominated by Abbott Laboratories.
Board room seats
Barton has served Abbott since joining in 1990

Allergic disorders specialist Allergy Therapeutics plc (LON:AGY) has announced a change of non-executive directors on the board.

Jean-Yves Pavee retired from the board last night and has been replaced by Jeff Barton, who has been nominated by Abbott Laboratories.

Barton currently serves as vice president of licensing and acquisitions at Abbott.

During his time in this role, Abbott has executed several strategically important transactions including the acquisition of St. Jude Medical, CFR Pharmaceuticals and Veropharm. 

“He brings extensive commercial experience, particularly in the United States, which will be valuable to our company as we continue to execute our global strategy. We also wish to take this opportunity to thank Jean-Yves for his contribution and support to Allergy Therapeutics since 2014," said Peter Jensen, chairman of Allergy Therapeutics.

John-H.jpg
Why Invest In Allergy Therapeutics plc? Read More Here

Register here to be notified of future AGY Company articles
View full AGY profile View Profile

Allergy Therapeutics plc Timeline

Related Articles

brain-scan.jpg
May 22 2017
In the six months ended March, revenues increased 31% to £2mln
Blood testing
February 13 2017
Identifying cancer cells early is a key part of combatting the disease, and ANGLE's Parsortix device looks to be developing into a key ally.
a child with asthma using an inhaler
September 22 2016
Phase II results for its prospective asthma treatment are due next year, while its LOXL2 collaboration with Pharmaxis is set for a Phase I trial in 2017

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use